Board of DirectorsThe Board of Directors is responsible for our company's corporate governance and ultimately accountable for our activities, strategy and performance. The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.
Sir Christopher Gent is Non-Executive Chairman of GlaxoSmithKline plc. He also serves as Chairman of the Nominations and Corporate Responsibility Committees.
 Find out more about Sir Christopher Gent
Andrew Witty is Chief Executive Officer of GlaxoSmithKline. He assumed this role in May 2008 after being appointed to the the Board in January 2008.
Find out more about Andrew Witty
Professor Sir Roy Anderson is the Professor of Infectious Disease Epidemiology in the Faculty of Medicine, Imperial College, London.
Find out more about Roy Anderson
Dr Stephanie Burns is Chairman, president and chief executive officer of Dow Corning.
Find out more about Stephanie Burns
Lawrence Culp is President and Chief Executive Officer of Danaher Corporation.
Find out more about Lawrence Culp 
Julian Heslop assumed the role of Chief Financial Officer for GlaxoSmithKline in April 2005.
Find out more about Julian Heslop 
Sir Deryck Maughan is an Independent Non-Executive Director and Managing Director of Kohlberg Kravis Roberts and Co. (KKR) and Chairman of KKR Asia.
Find out more about Sir Deryck Maughan 
James Murdoch is Chairman and Chief Executive of News Corporation, Europe and Asia.
Find out more about James Murdoch 
Dr Daniel Podolsky is an Independent Non-Executive Director and is Chief of Gastroenterology at Massachusetts General Hospital and Harvard Medical School.
Find out more about Dr Daniel Podolsky 
Moncef Slaoui assumed the role of Chairman, Research & Development, GlaxoSmithKline, in June 2006.
Find out more about Moncef Slaoui 
Tom de Swaan is an Independent Non-Executive Director and Chairman, Audit Committee.
Find out more about Tom de Swaan 
|
 
Investors
Annual Report 2008 |
| Membership of board committees is indicated in the table below | ||||||
| Audit | Corporate Administration & Transactions |
Corporate Responsibility | Financial Results | Nominations | Remuneration | |
| Gent | M | C | M | C | M | |
| Witty | M | M | ||||
| Anderson | M | M | M | |||
| Burns | M | M | M | |||
| Culp | M | M | M | M | ||
| Davis | M | M | M | C | ||
| De Swaan | C | M | M | M | ||
| Heslop | M | M | ||||
| Maughan | M | M | M | M | ||
| Murdoch | M | M | M | M | ||
| Podolsky | M | M | M | M | ||
| Slaoui | M | M | ||||
| Wilson | M | M | M | M | M | |
Key:
C = Chairman
M = Member
Back to top